Short Interest in International Stem Cell Co. (OTCMKTS:ISCO) Increases By 400.0%

International Stem Cell Co. (OTCMKTS:ISCO) saw a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 1,500 shares, a growth of 400.0% from the December 15th total of 300 shares. Based on an average daily volume of 22,400 shares, the days-to-cover ratio is currently 0.1 days.

International Stem Cell Trading Down 16.7 %

Shares of ISCO traded down $0.02 on Tuesday, reaching $0.10. The company’s stock had a trading volume of 10,055 shares, compared to its average volume of 4,939. International Stem Cell has a twelve month low of $0.05 and a twelve month high of $0.20. The stock has a market capitalization of $800,000.00, a PE ratio of -1.25 and a beta of 0.21. The firm has a fifty day moving average of $0.09 and a 200-day moving average of $0.08.

International Stem Cell Company Profile

International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.